THZ531 |
Covalent Inhibitor of CDK12, CDK13
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CDK12 |
|
|
| CDK13 |
|
|
Covalent Inhibitor
50-500 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC 50 - 8500 nM CDK7, 10500 nM CDK9
Selectivity Assessment Description:
Ambit profiling indicated that CDK13 was among the top scoring kinases. KiNativ profiling confirmed ...
Potency Cellular
In Vitro
CDK12
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1038/nchembio.2166
CDK13
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1038/nchembio.2166
Negative Control Compounds
THZ531R
THZ532
Chemical Information
| Molecular Formula | C30H32ClN7O2 |
| SMILEs | CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1 |
| InChI | InChI=1S/C30H32ClN7O2/c1-37(2)15-6-10-27(39)34-21-13-11-20(12-14-21)29(40)38-16-5-7-22(19-38)35-30-33-18-25(31)28(36-30)24-17-32-26-9-4-3-8-23(24)26/h3-4,6,8-14,17-18,22,32H,5,7,15-16,19H2,1-2H3,(H,34,39)(H,33,35,36)/b10-6+/t22-/m1/s1 |
| Molecular weight | 557.23 Da |
| AlogP | 5.0513 |
| HBond acceptors | 9 |
| HBond donors | 3 |
| Atoms | 72 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.